» Articles » PMID: 28108534

Cell Biology and Pathophysiology of α-Synuclein

Overview
Specialty General Medicine
Date 2017 Jan 22
PMID 28108534
Citations 260
Authors
Affiliations
Soon will be listed here.
Abstract

α-Synuclein is an abundant neuronal protein that is highly enriched in presynaptic nerve terminals. Genetics and neuropathology studies link α-synuclein to Parkinson's disease (PD) and other neurodegenerative disorders. Accumulation of misfolded oligomers and larger aggregates of α-synuclein defines multiple neurodegenerative diseases called synucleinopathies, but the mechanisms by which α-synuclein acts in neurodegeneration are unknown. Moreover, the normal cellular function of α-synuclein remains debated. In this perspective, we review the structural characteristics of α-synuclein, its developmental expression pattern, its cellular and subcellular localization, and its function in neurons. We also discuss recent progress on secretion of α-synuclein, which may contribute to its interneuronal spread in a prion-like fashion, and describe the neurotoxic effects of α-synuclein that are thought to be responsible for its role in neurodegeneration.

Citing Articles

α-Synuclein Degradation in Brain Pericytes Is Mediated via Akt, ERK, and p38 MAPK Signaling Pathways.

Yokoya M, Takata F, Iwao T, Matsumoto J, Tanaka Y, Aridome H Int J Mol Sci. 2025; 26(4).

PMID: 40004079 PMC: 11855147. DOI: 10.3390/ijms26041615.


α-Synuclein Iron-Responsive-Element RNA and Iron Regulatory Protein Affinity Is Specifically Reduced by Iron in Parkinson's Disease.

Khan M Biomolecules. 2025; 15(2).

PMID: 40001517 PMC: 11853559. DOI: 10.3390/biom15020214.


Multi-functional role of apolipoprotein E in neurodegenerative diseases.

Islam S, Noorani A, Sun Y, Michikawa M, Zou K Front Aging Neurosci. 2025; 17:1535280.

PMID: 39944166 PMC: 11813892. DOI: 10.3389/fnagi.2025.1535280.


Listerin promotes α-synuclein degradation to alleviate Parkinson's disease through the ESCRT pathway.

Qin F, Cao R, Cui W, Bai X, Yuan J, Zhang Y Sci Adv. 2025; 11(7):eadp3672.

PMID: 39937915 PMC: 11818022. DOI: 10.1126/sciadv.adp3672.


Alpha-Synuclein Fails to Form Aggregates in Endocytosis-Defective Fission Yeast Strains, ∆ and ∆ .

Takasaki T, Yamada R, Sugimoto Y, Sugiura R MicroPubl Biol. 2025; 2025.

PMID: 39911909 PMC: 11795301. DOI: 10.17912/micropub.biology.001479.


References
1.
Cuervo A, Stefanis L, Fredenburg R, Lansbury P, Sulzer D . Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science. 2004; 305(5688):1292-5. DOI: 10.1126/science.1101738. View

2.
Fernandez C, Hoyer W, Zweckstetter M, Jares-Erijman E, Subramaniam V, Griesinger C . NMR of alpha-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation. EMBO J. 2004; 23(10):2039-46. PMC: 424375. DOI: 10.1038/sj.emboj.7600211. View

3.
Polymeropoulos M, Lavedan C, Leroy E, Ide S, Dehejia A, Dutra A . Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997; 276(5321):2045-7. DOI: 10.1126/science.276.5321.2045. View

4.
Danielson S, Held J, Schilling B, Oo M, Gibson B, Andersen J . Preferentially increased nitration of alpha-synuclein at tyrosine-39 in a cellular oxidative model of Parkinson's disease. Anal Chem. 2009; 81(18):7823-8. PMC: 2748813. DOI: 10.1021/ac901176t. View

5.
Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E . The ubiquitin pathway in Parkinson's disease. Nature. 1998; 395(6701):451-2. DOI: 10.1038/26652. View